Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Researchers from Department of Experimental Psychology have found that, during lockdown, teenagers mental health is struggling compared to their parents.

School bag and equipment next to a face mask

The Oxford ARC study, launched in May, has found that teenagers consistently report higher levels of anxiety and depression than parents. Around 35% of teenagers are saying they feel lonely often or most of the time, compared to 17% of parents. At the same time, about 40% of parents say they never feel lonely, compared to only 20% of teenagers. Since May, teenagers consistently reported that they felt unable to control the important things in life, with rates as high as 60% last month.

Now, millions of teenagers are returning to school. Far from being a typical return to school after summer break, this year’s students will bring with them unique experiences, worries, and traumas from lockdown during this global pandemic lockdown.

The Oxford ARC study, is launching a new phase of research in order to understand how certain aspects of the school experience are helping or harming young people’s mental health during the transition back to school and into the ‘new normal’. Teenagers interested in taking part can go to the Oxford ARC website to find out more.

The full story is available on the University of Oxford website

This story is also discussed in a Department of Experimental Psychology blog

Similar stories

Human challenge trial launches to study immune response to COVID-19

Clinical Trials Coronavirus COVID-19 General

Though the COVID-19 pandemic has now been active for a year, not much is known about what happens when people who have already had COVID-19 are infected for a second time.

Risk of rare blood clotting higher for COVID-19 than for vaccines

Coronavirus COVID-19 Research

COVID-19 leads to a several-times higher risk of cerebral venous thrombosis (CVT) blood clots than current COVID-19 vaccines.

Alternating vaccines trial expands to include two additional vaccines

Clinical Trials Coronavirus COVID-19 General

Researchers running the Com-Cov study, launched in February to investigate alternating doses of the Oxford-AstraZeneca vaccine and the Pfizer vaccine, have today announced that the programme will be extended to include the Moderna and Novavax vaccines in a new study.

Oxford medical students launch flagship raffle in aid of NHS heroes and lifesaving medical equipment

General

Tingewick, a society formed of medical students from Oxford University, are hosting a virtual charity raffle. With over 70 amazing prizes, ranging from Truck festival tickets to restaurant vouchers to bags of books and even a bike, the raffle is an exciting way to celebrate lockdown lifting by supporting many wonderful Oxfordshire businesses whilst raising lots of money for charity.

Asthma drug budesonide shortens recovery time in non-hospitalised patients with COVID-19

Clinical Trials Coronavirus COVID-19 Research

Inhaled budesonide, a common corticosteroid, is the first widely available, inexpensive drug found to shorten recovery times in COVID-19 patients aged over 50 who are treated at home and in other community settings, reports the PRINCIPLE trial in 1,779 participants.